Reply: Missing ligand model in autologous stem cell transplantation

Por Leung, W, Handgretinger, R, Turner, V, Hale, G A
Publicado em 2008

Inhibitory KIR–HLA receptor–ligand mismatch in autologous haematopoietic stem cell transplantation for solid tumour and lymphoma

Por Leung, W, Handgretinger, R, Iyengar, R, Turner, V, Holladay, M S, Hale, G A
Publicado em 2007

Comparison of the Effects of Streptokinase and Heparin on the Early Rate of Resolution of Major Pulmonary Embolism

Por Hirsh, J., McDonald, I. G., Hale, G. A., O'Sullivan, E. F., Jelinek, V. M.
Publicado em 1971

Efficacy of high-dose methotrexate, ifosfamide, etoposide and dexamethasone salvage therapy for recurrent or refractory childhood malignant lymphoma

Por Sandlund, J. T., Pui, C-H., Mahmoud, H., Zhou, Y., Lowe, E., Kaste, S., Kun, L. E., Krasin, M. J., Onciu, M., Behm, F. G., Ribeiro, R. C., Razzouk, B. I., Howard, S. C., Metzger, M. L., Hale, G. A., Rencher, R., Graham, K., Hudson, M. M.
Publicado em 2011

No increased mortality from donor or recipient hepatitis B- and/or hepatitis C-positive serostatus after related-donor allogeneic hematopoietic cell transplantation

Por Tomblyn, M., Chen, M., Kukreja, M., Aljurf, M.D., Al Mohareb, F., Bolwell, B.J., Cahn, J.-Y., Carabasi, M.H., Gale, R.P., Gress, R.E., Gupta, V., Hale, G.A., Ljungman, P., Maziarz, R.T., Storek, J., Wingard, J.R., Young, J.-A.H., Horowitz, M.M., Ballen, K.K.
Publicado em 2012